Garten et al. [20] reported that overexpression of SIRT1 significantly decreased sorafenib-induced apoptosis, which could be an underlying mechanism of resistance to sorafenib treatment in hepatocellular carcinoma (HCC). This evidence concerns the gene SIRT1 and hepatocellular carcinoma.